{"id":"NCT00182000","sponsor":"Massachusetts General Hospital","briefTitle":"Effectiveness of D-Cycloserine as an Aid to Enhance Learning for Individuals With OCD Receiving Behavior Therapy","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled Medication Trial With D-Cycloserine for Individuals With OCD Currently Receiving Behavior Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-11","primaryCompletion":"2008-01","completion":null,"firstPosted":"2005-09-16","resultsPosted":"2012-07-06","lastUpdate":"2012-07-16"},"enrollment":33,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Obsessive-Compulsive Disorder"],"interventions":[{"type":"DRUG","name":"seromycin","otherNames":["D-Cycloserine"]},{"type":"BEHAVIORAL","name":"Behavior Therapy","otherNames":[]}],"arms":[{"label":"Seromycin","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study will assess the effectiveness of Seromycin (D-cycloserine) in enhancing the positive effects of behavior therapy for people with Obsessive-Compulsive Disorder (OCD).","primaryOutcome":{"measure":"Yale-Brown Obsessive Compulsive Scale (YBOCS)","timeFrame":"Post-treatment (week 5)","effectByArm":[{"arm":"Seromycin","deltaMin":10.2,"sd":7.2},{"arm":"Placebo","deltaMin":14.5,"sd":6.4}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":10},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":14},"commonTop":[]}}